In this edition, elevated cardiotoxicity risk for Black patients after chemotherapy; CV risk factor disparities in childhood cancer survivors; neural network helps identify potential targets for cancer drugs and more. Read the full coverage here: Black patients may be at elevated cardiotoxicity, HF risk after chemotherapy CV risk factor disparities in childhood cancer survivors similar to general population Neural network helps identify many more potential targets for cancer drugs Blood or marrow transplant survivors at high risk for malignant neoplasms in the GI tract Optimizing CV health behaviors may lower risk for CVD and cancer References: Gebeyehu W, et al. Original Research Abstract 56. Presented at: American College of Cardiology's Advancing the Cardiovascular Care of the Oncology Patient conference; April 14-16, 2023; Washington, D.C. (hybrid meeting). McDonald A, et al. JAMA Oncol. 2023;doi:10.1001/jamaoncol.2022.6569. Meller A, et al. Nat Commun. 2023;doi:10.1038/s41467-023-36699-3. Noyd DH, et al. JACC CardioOncol. 2023;doi:10.1016/j.jaccao.2023.01.011. van Sloten T, et al. JACC CardioOncol. 2023;doi:10.1016/j.jaccao.2022.11.015.

Ver todos los episodios